CDH1 and cancer: No statistically significant correlation between E-cadherin and β-catenin was revealed in the poorly-differentiated (G3) cancers (P=0.121, r=0.234), in the tumors of pT1 or pT2 (P=0.381, r−0.254) or in the subgroup of mucinous adenocarcinomas (P=0.983, r=−0.005) (Table IV).